Dry Powder Inhaler Devices Market : Demand, Upcoming Trends and Business Opportunity 2021 to 2028

The Dry Powder Inhaler Devices Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Over the next few years, the Dry Powder Inhaler Devices market will register a 4.9% CAGR (approx.) in terms of revenue, the global market size will reach US$ 978.8 million by 2028.

Get Sample Copy Of This Report + All Related Graphs (Covid-19 Update):

https://www.marketinsightsreports.com/reports/05052869934/2016-2028-global-dry-powder-inhaler-devices-industry-market-research-report-segment-by-player-type-application-marketing-channel-and-region/inquiry?source=OpenPr&Mode=12             

The report presents the market competitive landscape and a corresponding detailed analysis of the major vendor/key players in the market. Top Companies in the Global Dry Powder Inhaler Devices Market: Luckys Pharma, Cipla Inc., Teicos Pharma Ltd., Beximco Pharma Ltd., GlaxoSmithKline Plc., AstraZeneca Plc., Hovione FarmaCiencia SA., Presspart Manufacturing Ltd., Bespak Europe Ltd., SRS Pharmaceuticals Pvt. Ltd, Catalent, Inc. and others.

Some Of The Recent Developments In The Market Are As Follows:

Iconovo presents new inhaler ICOpre at RDD

28-Apr-2021: Iconovo has invested heavily in developing a new pre-metered dual cavity inhaler under the name ICOpre. The company is now presenting the inhaler to the outside world for the first time at the international Respiratory Drug Delivery 2021 conference. Details of the design, function and development process of ICOpre will be presented at a workshop at the RDD conference.

Iconovo develops complete inhalation products, i.e., inhalers and associated dry powder formulations, which are licensed to pharmaceutical and generic companies. This means that customers do not have to carry out complex and costly stages in the development process, leading to a faster way to the inhalation market together with lower risk and lower cost.

The fourth and latest addition to Iconovo’s family with inhalation platforms is the pre-filled dual cavity inhaler ICOpre. Yesterday, the company announced that ICOpre will be shown publicly for the first time at a workshop at the Respiratory Drug Delivery 2021 (RDD) virtual conference, which will take place 4-7 May. During the workshop, ICOpre will be used as an example of how Iconovo’s concept can help overcome challenges when developing generic inhalation products.

FDA Approval for Mylan’s Generic Advair®

31/01/19 -- Consort Medical plc (LSE: CSRT) (“Consort” or “Consort Medical”), a leading developer and manufacturer of drugs and premium drug delivery devices, notes the announcement from the US Food and Drug Administration (FDA) that it has granted abbreviated new drug application (ANDA) approval for Mylan’s WixelaTM InhubTM (fluticasone propionate and salmeterol inhalation powder, USP), the first FDA-approved generic of ADVAIR DISKUS® (fluticasone propionate and salmeterol inhalation powder).

Consort has constructed a 5,500 square metre dedicated building and clean room at its King’s Lynn site with appropriate manufacturing capacity to support Mylan in producing the proprietary dry powder inhaler (DPI) for their generic of Advair Diskus. As detailed in our interim results announcement, Consort looks forward to continuing to support Mylan on their product launch.

Global Dry Powder Inhaler Devices Market Split by Product Type and Applications:

This report segments the market on the basis of Types are:

Single dose inhalers
Multi-dose inhalers

On the basis of Application, the market is segmented into:

Asthma
Chronic Obstructive Pulmonary Disease
Pulmonary Arterial Hypertension
Others

Buy The Report:
https://www.marketinsightsreports.com/report/purchase/05052869934?mode=su?source=OpenPr&Mode=12                   

Regional Analysis For Dry Powder Inhaler Devices Market:

For comprehensive understanding of market dynamics, the global Dry Powder Inhaler Devices market is analyzed across key geographies namely:

North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Dry Powder Inhaler Devices Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger and acquisitions along with trending innovation and business policies are reviewed in the report. The report contains basic, secondary and advanced information pertaining to the Market global status and trend, market size, share, growth, trends analysis, segment and forecasts from 2021–2027.                 

Key Points of Dry Powder Inhaler Devices Market Table of Contents:

-Market Overview: The report begins with this section where a product overview and key content on the product and application segments of the global Halal Foods market are provided. The highlights of the segmentation study include price, revenue, sales, sales growth rate, and market share by product.

-Competition by company: Here we analyze the competition of the global Dry Powder Inhaler Devices market, by company price, revenue, sales and market share, market share, competitive landscape, and latest trends, mergers, expansions, acquisitions, and market share of top companies.

-Company Profile and Sales Data: As the name suggests, this section provides sales data and useful information about the business of key players in the global Dry Powder Inhaler Devices market. It describes the key businesses of gross margin, price, revenue, products and specifications, types, applications, competitors, manufacturing base, and key players operating in the global Dry Powder Inhaler Devices market.

-Market Forecast: Here the report provides a full forecast for the global Dry Powder Inhaler Devices market by product, application, and region. It also provides global sales and revenue forecasts for all years in the forecast period.

-Research Results and Conclusion: One of the last sections of the report where analyst findings and findings are provided.

For More Information On This Report, Please Visit: https://www.marketinsightsreports.com/reports/05052869934/2016-2028-global-dry-powder-inhaler-devices-industry-market-research-report-segment-by-player-type-application-marketing-channel-and-region?source=OpenPr&Mode=12          

Due to the onset of COVID-19 pandemic, several economies across the world have experienced harsh economic downturn. The industrialists across North America, Europe, Asia Pacific, Latin America and Middle East and Africa were facing problems due to changing preferences of the customers and demand fluctuation. The market research report covers pre-Covid-19 data for the Dry Powder Inhaler Devices market in years 2018 and 2020. Further, the report also covers forecast Covid-19 data from 2021 to 2028, which provides future outlook of the market for the manufacturers and suppliers.

Browse Related Reports:

Digital Dose Inhalers Industry Market:

https://www.marketinsightsreports.com/reports/06022954603/2016-2028-global-digital-dose-inhalers-industry-market-research-report-segment-by-player-type-application-marketing-channel-and-region?source=OpenPr&Mode=12                

Nitroglycerin Inhaler Industry Market:

https://www.marketinsightsreports.com/reports/06022951950/2016-2028-global-nitroglycerin-inhaler-industry-market-research-report-segment-by-player-type-application-marketing-channel-and-region?source=OpenPr&Mode=12                    

Smart Inhaler Technology Market:

https://www.marketinsightsreports.com/reports/06022951369/2016-2028-global-smart-inhaler-technology-industry-market-research-report-segment-by-player-type-application-marketing-channel-and-region?source=OpenPr&Mode=12            

Customization Of The Report:

MarketInsightsReports provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.     

If you have any questions about any of our “Dry Powder Inhaler Devices market report” or would like to schedule a personalized free demo of Dry Powder Inhaler Devices market report, please do not hesitate to contact me at irfan@marketinsightsreports.com.

Best wishes,

Irfan Tamboli

Head of Sales Operations

Market Insights Reports

Tel: + 1704 266 3234 | +91-750-707-8687

Email: sales@marketinsightsreports.com | irfan@marketinsightsreports.com

About Us:

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides Global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.